Author

Jeffrey Hyams

LINACLOTIDE SAFETY AND EFFICACY IN CHILDREN AGED 7 TO 17 YEARS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION
LINACLOTIDE SAFETY AND EFFICACY IN CHILDREN AGED 7 TO 17 YEARS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION

Jeffrey Hyams  et al.

PHARMACOKINETICS, EFFICACY AND SAFETY OF MIRIKIZUMAB AS INDUCTION THERAPY IN PAEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2 SHINE-1 STUDY
PHARMACOKINETICS, EFFICACY AND SAFETY OF MIRIKIZUMAB AS INDUCTION THERAPY IN PAEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2 SHINE-1 STUDY

Jeffrey Hyams  et al.

Item 1 - 2 / 2
1